Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Anemia
•
Hematology
•
Benign Hematology
In a patient with cold agglutinin disease on observation, when do you suspect Waldenstrom macroglobulinemia?
Do you prefer following IgM level or M protein?
Related Questions
Is bone marrow biopsy indicated in patients with primary polycythemia but negative for JAK2 mutation including exon 12?
In what situations would you consider ESAs in hospitalized patients with severe anemia for indications other than CKD or myelosuppressive chemotherapy (e.g., ACD, hemorrhage)?
How would you treat cold agglutinin disease secondary to underlying marginal zone lymphoma with only bone marrow involvement and no disease elsewhere?
How would you manage a pre-menopausal woman with extranodal marginal zone lymphoma confined to the bladder wall?
When utilizing ISRT for Hodgkin lymphoma, what volumetric expansions (ITV and PTV) are appropriate on top of the CTV that includes the original pre-systemic therapy disease?
How would you manage an early isolated CNS relapse in a pediatric patient with Ph positive ALL?
Would you offer consolidative scrotal RT for patients with bilateral testicular lymphoma involvement s/p bilateral orchiectomy and chemotherapy?
How would you manage an elderly patient with mild pancytopenia who refuses bone marrow biopsy and whose flow cytometry is suggestive of CMML/MDS?
How soon after CAR T-cell therapy can salvage radiation be delivered?
How do you discuss harms of MGUS screening with other medical providers?
